Inventor · disambiguated record
Min-Fun Rudolf Kwan
Also filed as: KWAN MIN-FUN RUDOLF
6 granted patents·8 pending applications·11 citations·filing 2016–2022
76Inventor score
Files withATHENEX HK INNOVATIVE LTD5ATHENEX INC4ATHENEX THERAPEUTICS LTD3ATNX SPV LLC1KINEX THERAPEUTICS HK LTD1
Top patents by PatentIndex Score
14 records- 0190US10617693B2Methods of treating and/or preventing actinic keratosisATHENEX INC·Filed 2018·Granted Apr 14, 2020·6 cites·25 claims
- 0287US11497750B2Methods of treating and/or preventing actinic keratosisATHENEX INC·Filed 2020·Granted Nov 15, 2022·2 cites·23 claims
- 0385US10849893B2Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancerATHENEX HK INNOVATIVE LTD·Filed 2019·Granted Dec 1, 2020·2 cites·32 claims
- 0482US11389442B2Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancerATHENEX HK INNOVATIVE LTD·Filed 2020·Granted Jul 19, 2022·1 cites·19 claims
- 0570US2023046869A1Therapeutic combinations of orally administered docetaxel and a p-gp inhibitor for the treatment of cancerATHENEX HK INNOVATIVE LTD·Filed 2022·Application pending·0 cites
- 0666US2023181566A1THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF ANGIOSARCOMAATHENEX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0765US2023172942A1Methods of treating and/or preventing actinic keratosisATNX SPV LLC·Filed 2022·Application pending·0 cites
- 0864US2023172926A1THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCERATHENEX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0961US2024390360A1Therapeutic Combinations Of Orally Administered Paclitaxel, A P-gp Inhibitor, And A Checkpoint Inhibitor For The Treatment Of Solid TumorsATHENEX INC·Filed 2022·Application pending·0 cites
- 1058US2019314361A1THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF ANGIOSARCOMAATHENEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1156US11752139B2Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancerATHENEX HK INNOVATIVE LTD·Filed 2019·Granted Sep 12, 2023·0 cites·16 claims
- 1246US2022305021A1Methods of treating and/or preventing psoriasisATHENEX INC·Filed 2020·Application pending·0 cites
- 1339US2018207148A1THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCERKINEX THERAPEUTICS HK LTD·Filed 2016·Application pending·0 cites
- 1436US11752156B2Compositions and methods for treating hyperproliferative skin disordersATHENEX HK INNOVATIVE LTD·Filed 2019·Granted Sep 12, 2023·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Min-Fun Rudolf Kwan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →